摘要 |
<p>Methods for the treatment and prevention of pulmonary infections are disclosed, in particular, methods comprising the administration of one or more anti-selectin agents to a patient diagnosed with a pulmonary infection. Anti-selectin agents that inhibit leukocyte recruitment to the lungs have been found to be beneficial for the treatment of lung infections, including infections associated with chronic bronchitis, chronic obstructive pulmonary disease (COPD), pneumonia, pneumonitis, acute respiratory distress syndrome (ARDS), severe acute respiratory syndrome (SARS), sarcoidosis, cystic fibrosis (CF), emphysema, asthma, smoker's cough, allergy, allergic rhinitis, sinusitis and pulmonary fibrosis.</p> |
申请人 |
LIGOCYTE PHARMACEUTICALS, INC.;MONTANA STATE UNIVERSITY |
发明人 |
JUTILA, MARK A.;BARGATZE, ROBERT F.;PALECANDA, AIYAPPA;GLEE, PATI M. |